Jones Trading on Praxis Precision Medicines Inc. (PRAX): 'one step closer to becoming a commercial-stage company'
Tweet Send to a Friend
Jones Trading analyst Justin Walsh reiterated a Buy rating and $441.00 price target on Praxis Precision Medicines Inc. (NASDAQ: PRAX)The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
